Trials / Completed
CompletedNCT04309994
Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 307 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The goal of this study is to compare the two cardioplegia solutions (blood cardioplegia by means of MPS ® vs. Cardioplexol ®) regarding perioperative outcome and with special attention to cardiac markers in patients with a recent heart attack.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Myocardial protection system (MPS) | cardioplegia solution, A separate pumpsystem by which Blood cardioplegia with individually composable additives as cardioplegia solution can be used |
| OTHER | Cardioplexol | cardioplegia solution |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
- First posted
- 2020-03-17
- Last updated
- 2020-03-17
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04309994. Inclusion in this directory is not an endorsement.